The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas

The oncogenic transcription factor Myc is required for the progression and maintenance of diverse tumors. This has led to the concept that Myc itself, Myc-activated gene products, or associated biological processes might constitute prime targets for cancer therapy. Here, we present an in vivo revers...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: D'Andrea, Aleco, Gritti, Ilaria, Nicoli, Paola, Giorgio, Marco, Doni, Mirko, Conti, Annalisa, Bianchi, Valerio, Casoli, Lucia, Sabò, Arianna, Mironov, Alexandre, Beznoussenko, Galina V., Amati, Bruno
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2016
Gaiak:
Priority Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5341918/
https://ncbi.nlm.nih.gov/pubmed/27635472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11719
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak